mRNA-4157,Pembrolizumab
Moderna,Merck
['mrna-4157', 'melanoma']
update from phase 2 mrna-4157 adjuvant melanoma vaccine. reduction in metastasis. looking forward to enrolling patients to the piii study.
#asco2023 #melanoma 
Director of clinical research, #oncology
The opinions are my personal ones.